arrow
T

Tetsuya Ishikawa

invalid.
H指数:27
被引数:2,868

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Angiographic residual stenosis and clinical outcomes after elective drug-coated balloon angioplasty for de novo coronary lesions: a single center retrospective study

经选择的药物涂层球囊血管成形术治疗原发冠状动脉病变后的血管造影残余狭窄和临床结局:一项单中心回顾性研究

2026-06-020
PRE
Effect of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention With Aspirin-Free Strategy

无阿司匹林策略下质子泵抑制剂对经皮冠状动脉介入治疗患者的影响

2026-02-011
OAAI
Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation

M201-A对阵发性及持续性心房颤动的安全性、有效性与潜在作用的药理学研究

2025-07-020
PRE
Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment Elevation

急性冠状动脉综合征伴高出血风险或ST段抬高1个月后阿司匹林与氯吡格雷的比较

2025-06-040
PRE
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial
2025-01-250
OAAI
An aspirin-free strategy for percutaneous coronary intervention in patients with diabetes: a pre-specified subgroup analysis of the STOPDAPT-3 trial
2024-10-231
PRE
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial
2024-08-311
OA
Aspirin-Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT-3 Trial
2024-08-060
OAAI
A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I study
2024-05-211
OA
An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention

复杂经皮冠状动脉介入治疗后立即治疗的无阿司匹林策略

2024-05-013
PRE
Cardiovascular Outcomes after Paclitaxel-Coated Balloon Angioplasty versus Drug-Eluting Stent Placement for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis

紫杉醇涂层球囊血管成形术与药物洗脱支架置入治疗急性冠状动脉综合征后的心血管结局:一项系统综述与荟萃分析

2024-03-043
OAAI
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial
2024-02-2048
PRE
Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial

基于急性冠状动脉综合征亚型和高出血风险的无阿司匹林经皮冠状动脉介入治疗的STOPDAPT-3试验

2024-01-295
PRE
Biodegradable or durable polymer drug-eluting stents in patients with coronary artery disease: ten-year outcomes of the randomised NEXT Trial
2023-08-013
PRE
Clinical and procedure characteristics in patients treated with polytetrafluoroethylene-covered stents after coronary perforation: a CIRC-8U multicenter registry and literature review
2020-10-094
PREAI